EXPO EXPONENT INC Insider Trading

EXPO CEO Catherine Corrigan sold 7,821 shares across 4 transactions for $528,639.06 (blended avg $67.59).

Catherine Corrigan, President & CEO, executed 4 separate sales totaling 7,821 shares for $528,639.06 between mid-March and mid-April 2026. The sales reduced her holdings from 112,180 shares to 104,359 shares, a -7.0% reduction in stake. The blended average sale price of $67.59 sits below the current price of $68.12 and well below the 52-week high of $80.98 (currently at -15.9% from peak). This modest reduction in CEO holdings occurs amid a company trading at a P/E of 32.75 with recent quarterly net income of $28.0M on $147.1M revenue, suggesting modest but reasonable financial performance relative to valuation.

Director Paul R Johnston sells 14,000 shares at $104.60 for $1,464,429.40; holdings fall to 80.7K shares

Director Paul R Johnston executed 2 separate sales totaling 14,000 shares for $1,464,429.40 on 2024-11-06. His post-transaction holdings stand at 80.7K shares, a -14.8% reduction from his prior position of 94.7K shares. The transaction occurred at $104.60 per share against a current price of $104.77, placing the sale within 0.2% of current levels and well below the 52-week high of $115.28. While the stock is up 0.8% over 90 days, EXPONENT trades at a P/E of 50.13 with recent quarterly revenue of $136.3M and net income of $26.0M, reflecting a moderately valued profile in a lower-volatility trading band. The sale does not constitute a full liquidation and leaves the director with a substantial continued stake in the company.

CFO Richard Schlenker sold 40,662 shares ($4.3M) at $106.71–$106.73 on 2024-07-31, reducing holdings by 15.4%.

Schlenker executed three separate sales totaling 40,662 shares for $4,339,184.29 at prices near the 52-week high of $106.96, an opportune exit point. His post-transaction holdings of 224,060 shares represent a -15.4% reduction versus his 264,722 prior shares. This is the second open-market sale by this executive; his cross-ticker track record shows 1 prior sell, with outcome not yet measurable. The company trades at a P/E of 52.28 and recently posted $30,142,000 in quarterly net income on $144,933,000 revenue. The stock has risen +11.3% over the past 30 days and +10.8% over 90 days, suggesting execution at an elevated valuation amid recent momentum.

CFO Schlenker sells 57,652 EXPO shares for $6.2M at $107.17; retains 236,164 shares post-transaction

Richard L Schlenker Jr, EVP & Chief Financial Officer, sold 57,652 shares on 2024-07-30 at $107.17, reducing his position by 19.6% to 236,164 shares outstanding. The sale occurred near the 52-week high ($106.96), with the stock trading at $106.08 currently and posting strong momentum (+13.5% over 30 days, +14.8% over 90 days). The company reported quarterly revenue of $144,933,000.00 and net income of $30,142,000.00, with annual growth of +4.6%, though the P/E of 53.04 reflects elevated valuation. The insider retains a substantial equity stake, and his prior cross-ticker open-market history shows 3 prior sells with no measurable timing pattern established at comparable scales.